Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives
The expression of estrogen receptors (ERs) in breast cancer (BC) represents a strong prognostic and predictive biomarker and directs therapeutic decisions in early and advanced stages. ER-low-positive BC, defined by the immunohistochemical (IHC) expression of ERs from 1% to 9%, constitutes a distinc...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2023-11-01
|
| coleção: | Current Oncology |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/1718-7729/30/11/706 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
